Ubs Asset Management Americas Inc Procept Bio Robotics Corp Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 201,451 shares of PRCT stock, worth $6.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
201,451
Previous 153,158
31.53%
Holding current value
$6.93 Million
Previous $8.92 Million
30.05%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PRCT
# of Institutions
290Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$180 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$120 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.2 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$53.9 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$52.5 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.53B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...